SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform

Sep 7 2023
With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data- driven treatment planning for a dvanced ovarian cancer BOSTON and ROLLE, Switzerland , Sept. 7, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles